On June 14, 2017 Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, reporte that Norman Michael Greenberg, Ph.D., Senior Vice President and Chief Scientific Officer, will participate in a panel discussion on immuno-oncology being held during the 2017 BIO International Conference on Thursday, June 22, 2017, from 10:15 a.m. – 11:15 a.m. PT in San Diego, CA (Press release, Atreca, JUN 14, 2017, View Source [SID1234522950]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The panel, titled "Immune-Oncology Drugs: Ready for First Line Therapy?", will take place in Room 7A in the San Diego Convention Center.